Sept 5 (Reuters) - Opthea Ltd OPT.AX :
* OPTHEA RECEIVES POSITIVE INTERIM REVIEW FROM INDEPENDENT SAFETY COMMITTEE IN PHASE 2B WET AMD CLINICAL TRIAL
* OPTHEA LTD - REMAINS ON-TRACK TO REPORT PRIMARY DATA FROM STUDY IN EARLY 2020
* OPTHEA LTD - INDEPENDENT SAFETY COMMITTEE IN PHASE 2B WET AMD CLINICAL TRIAL UNANIMOUSLY RECOMMENDED TRIAL CONTINUE WITHOUT MODIFICATION